The predictive role of C‐reactive protein in patients with hypertension and subclinical atherosclerosis

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Internal medicine journal (Print)

• Publication date

  2009-03-23

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1445-5994.2009.01955.xPMID 19323703
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Detection, Evaluation, and Treatment of High Blood Cholesterol Education Program (NCEP) Expert Panel on Executive Summary of the Third Report of the National

  2009cited by this paper
• Mediterranean diet has no effect on markers of inflammation and metabolic risk factors in patients with coronary artery disease

  2006cited by this paper
• C-reactive protein, adiposity and cardiovascular risk factors in a Mediterranean population

  2006cited by this paper
• Coronary artery disease progression is associated with C-reactive protein and conventional risk factors but not soluble CD40 ligand.

  2006cited by this paper
• Association of elevated fibrinogen and C-reactive protein levels with carotid lesions in patients with newly diagnosed hypertension or type II diabetes.

  2006cited by this paper
• Increased levels of C-reactive protein and fibrinogen influence the risk of vascular events in patients with NIDDM.

  2006cited by this paper
• Markers of inflammation and infection influence the outcome of patients with baseline asymptomatic carotid lesions: a 5-year follow-up study.

  2006cited by this paper
• Inflammation and Carotid Artery—Risk for Atherosclerosis Study (ICARAS)

  2005cited by this paper
• Progression of native coronary plaques and in-stent restenosis are associated and predicted by increased pre-procedural C reactive protein

  2005cited by this paper
• Relationship Between C-Reactive Protein and Subclinical Atherosclerosis: The Dallas Heart Study

  2005cited by this paper
• Role of Inflammation and Infection in Vascular Disease

  2005cited by this paper
• Association of high sensitivity C-reactive protein with coronary heart disease prediction, but not with carotid atherosclerosis, in patients with hypertension.

  2004cited by this paper
• Inflammation and Atherosclerosis

  2004cited by this paper
• CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice Report From the Laboratory Science Discussion Group

  2004cited by this paper
• Relationship Between C-Reactive Protein and Progression of Early Carotid Atherosclerosis in Hypertensive Subjects

  2004cited by this paper
• Effect of carotid atherosclerosis screening on risk stratification during primary cardiovascular disease prevention.

  2004cited by this paper
• CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: report from the clinical practice discussion group.

  2004cited by this paper
• European Society of Hypertension – European Society of Cardiology guidelines for the management of arterial hypertension

  2003cited by this paper
• Early-Onset Carotid Atherosclerosis Is Associated With Increased Intima-Media Thickness and Elevated Serum Levels of Inflammatory Markers

  2003cited by this paper
• 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension.

  2003cited by this paper
• High sensitivity C-reactive protein in cardiovascular risk assessment. CRP mania or useful screening?

  2003cited by this paper
• High-sensitivity C-reactive protein in high-grade carotid stenosis: risk marker for unstable carotid plaque.

  2003cited by this paper
• Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events.

  2002cited by this paper
• Long-Term Effects of Inflammation-Sensitive Plasma Proteins and Systolic Blood Pressure on Incidence of Stroke

  2002cited by this paper
• Inflammation and Atherosclerosis

  2002cited by this paper
• Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events*

  2002cited by this paper
• C-reactive protein and incident coronary heart disease in the Atherosclerosis Risk In Communities (ARIC) study.

  2002cited by this paper
• Effect of Hydroxymethyl Glutaryl Coenzyme A Reductase Inhibitor Therapy on High Sensitive C-Reactive Protein Levels

  2001cited by this paper
• Is C-reactive protein an independent risk factor for essential hypertension?

  2001cited by this paper
• High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease.

  2001cited by this paper
• CAROTID-ARTERY INTIMA AND MEDIA THICKNESS AS A RISK FACTOR FOR MYOCARDIAL INFARCTION AND STROKE IN OLDER ADULTS

  2000cited by this paper
• Long-Term Effects of Pravastatin on Plasma Concentration of C-reactive Protein

  1999cited by this paper
• Long-term effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol and Recurrent Events (CARE) Investigators.

  1999cited by this paper
• Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group.

  1999cited by this paper
• C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992.

  1999cited by this paper
• C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction.

  1998cited by this paper
• Arterial wall thickness is associated with prevalent cardiovascular disease in middle-aged adults. The Atherosclerosis Risk in Communities (ARIC) Study.

  1995cited by this paper
• Microparticle‐enhanced nephelometric immunoassay for human C‐reactive protein

  1992cited by this paper
• Determination of cholesterol in sub-nanomolar quantities in biological fluids by high-performance liquid chromatography.

  1992cited by this paper
• Vascular Risks of Asymptomatic Carotid Stenosis

  1991cited by this paper
• Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging.

  1986cited by this paper

• A Review on New Drug Development for the Treatment of Neurodegenerative Disease

  2024cites this paper
• Impact of Intermittent Hypoxia Related to Obstructive Sleep Apnoea Syndrome on Low-Grade Inflammation in Hypertensive Patients: Potential Implications for Cardiovascular Risk

  2024cites this paper
• Synergistic Effects of Inflammation and Atherogenic Dyslipidemia on Subclinical Carotid Atherosclerosis Assessed by Ultrasound in Patients with Familial Hypercholesterolemia and Their Family Members

  2022cites this paper
• Role of neuroinflammation in neurodegenerative diseases (Review)

  2016cites this paper
• Prospective case‐controlled sound localisation study after cochlear implantation in adults with single‐sided deafness and ipsilateral tinnitus

  2016cites this paper
• Prognostic Value of C-Reactive Protein in Resistant Hypertension.

  2016cites this paper
• Age-related hypoxia in CNS pathology.

  2016cites this paper
• Evaluation of aortic elastic properties in patients with exaggerated systolic blood pressure response to exercise testing

  2015cites this paper
• Neuroinflammation and comorbidities are frequently ignored factors in CNS pathology

  2015influential citation
• The spectrum of risk factors for contrast induced nephropathy in patients undergoing coronary angiography or intervention

  2014cites this paper
• High plasma levels of endothelin-1 enhance the predictive value of preclinical atherosclerosis for future cerebrovascular and cardiovascular events: a 20-year prospective study

  2014cites this paper
• The Use of Soluble Intercellular Adhesion Molecule-1 and Soluble Vascular Cell Adhesion Molecule-1 as Potential Biomarkers in Patients with Atherosclerotic Cerebrovascular Disease

  2013cites this paper
• Does Inflammation Determine Whether Obesity Is Metabolically Healthy or Unhealthy? The Aging Perspective

  2012cites this paper
• The Transcription Levels of ABCA1, ABCG1 and SR-BI are Negatively Associated with Plasma CRP in Chinese Populations with Various Risk Factors for Atherosclerosis

  2012cites this paper
• Relationships between high-sensitive C-reactive protein and markers of arterial stiffness in hypertensive patients. Differences by sex

  2012cites this paper
• Is a new waist circumference and BMI needed for African Americans for the diagnosis of metabolic syndrome

  2012cites this paper
• Association of high-sensitivity C-reactive protein with carotid artery intima-media thickness in hypertensive older adults.

  2011cites this paper
• Efectos de olmesartán y lercanidipino sobre el daño vascular y la presión arterial ambulatoria en pacientes hipertensos no tratados

  2011cites this paper
• PREVALENCE OF OBESITY AND DIABETES IN CORONARY ARTERY DISEASE

  2011cites this paper
• Primary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive survey

  2011influential citation
• Platelet aggregation in arterial hypertension: Is there a nitric oxide–urea connection?

  2010cites this paper
• An update on the role of markers of inflammation in atherosclerosis.

  2010cites this paper
• Prehypertensive African-American Women Have Preserved Nitric Oxide and Renal Function but High Cardiovascular Risk

  2010influential citation
• Increased C-reactive protein is associated with future development of diabetes mellitus in essential hypertensive patients

  2010cites this paper
• C-Reactive Protein Promotes Cardiac Fibrosis and Inflammation in Angiotensin II-Induced Hypertensive Cardiac Disease

  2010cites this paper